TOPIC CENTER
818 Articles
Updated Oct 6, 2026
Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
Discovery & DevelopmentViking Therapeutics Advances Obesity Drug to Phase 3 with $300M Clinical Program
4 min read • 2 years ago -
Discovery & DevelopmentRoche Accelerates Obesity Treatment Development with Carmot Acquisition
4 min read • 2 years ago -
Funding & InvestmentsTriastek and BioNTech Collaborate on 3D-Printed RNA Therapeutics
4 min read • 2 years ago -
Regulatory & ComplianceDrug Development Costs Set to Increase Amid BIOSECURE Act
4 min read • 2 years ago -
-
-
-
Regulatory & ComplianceDo GLP-1 Drugs Pose a Threat to National Healthcare Systems?
4 min read • 2 years ago -
-
-
-
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.
